Background: Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease. occurring in up to 40% of patients with IBD. Despite the huge therapeutic progress of the last decade. one must not forget about the side effects that currently available medications might have and the challenges to both patient and physician. https://www.opheliasmuse.com/